What changed 10-Q

Item 1. Legal Proceedings

2025-08-05 compared with 2025-05-06 · 1 added, 1 removed, 16 unchanged (11% of the section changed)

13 unchanged sentences

We served an answer to Annora’s invalidity and non-infringement contentions in March 2023.

In March 2025, we entered into a settlement agreement with Annora resolving patent litigation related to our product TAVALISSE.

As reported in our Form 10-Q for the first quarter of 2025, in March 2025, we entered into a settlement agreement with Annora resolving patent litigation related to our product TAVALISSE.

Under the terms of the settlement agreement, Annora will have a license to sell its generic product in the second quarter of 2032 or earlier under certain circumstances.

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.